[Use of chlotazol as an immunomodulating agent in chronic bronchitis].
A positive immunomodulatory effect was found in chronic bronchitis patients examined immunologically before and after treatment including chlotazol. T- and B-cell immunity recovered, clinical condition of the patients improved. A combination of known antimicrobial and antiinflammatory effects with an uncovered immunomodulatory one made chlotazol a valuable modality in the treatment of chronic bronchitis associated with secondary immune deficiency.
Kleĭner
A I
AI
Shmuter
L M
LM
Makotchenko
V M
VM
Efremova
V A
VA
Khodzhaĭ
Ia I
IaI
Trukh
V S
VS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology* / Q000473:pathology; D001991:Bronchitis / Q000188:drug therapy* / Q000276:immunology; D002697:Chloral Hydrate / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008231:Lymphopenia / Q000188:drug therapy* / Q000209:etiology; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D013844:Thiazoles / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013844:Thiazoles; D002697:Chloral Hydrate; C034140:chlotazol
Primenenie khlotazola v kachestve immunomoduliruiushchego sredstva pri khronicheskom bronkhite.